Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Cash Management
5 Keys for Managing Bank Risk
Diversifying financial institutions is vital right now, but so are developing a continuity plan and preserving capital.
By
Vincent Ryan
| March 22, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
Cash Management
5 Keys for Managing Bank Risk
Diversifying financial institutions is vital right now, but so are developing a continuity plan and preserving capital.
By
Vincent Ryan
| March 22, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
Botox
M&A
Botox Maker Allergan Sold to AbbVie for $63B
AbbVie faces pressure to diversify its portfolio as Humira, the world’s best-selling drug, faces increased competition from cheaper versions in Europe.
By
Lauren Muskett
| June 25, 2019
Read More
Strategy
Allergan Buys CoolSculpting Company for $2.4B
The acquisition of Zeltiq Aesthetics' system for using cooling to eliminate fat cells gives Allergan access to the growing body-contouring market.
By
Matthew Heller
| February 13, 2017
Read More
